Citation

De Gier JJ. Transp. Res. Circular 2006; (E-C096): 68-77.

Copyright

(Copyright © 2006, U.S. National Academy of Sciences Transportation Research Board)

DOI

unavailable

PMID

unavailable

Abstract

This paper presents an overall assessment of the effects of medicinal drug use on driving performance from the literature on epidemiology, impairment, risk assessment and risk factors, risk perception, risk communication, and assessment of fitness to drive. In reviewing the literature some common findings are presented allowing us to make up our minds and to conclude how our present knowledge will guide us to actions in order to prevent the use of medicinal drugs to be of concern to traffic safety. The discussion covers the prevalence and epidemiology of drugs other than alcohol in road traffic; the prevalence of drug driving among the general population; the prevalence of medicinal drug driving among the general driver population; the prevalence of medicinal drug driving among driving under the influence of drugs (DUID) suspected drivers; the prevalence of medicinal drug use in accident-involved drivers; impairment of driving performance; and risk assessment.